Properties (65)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
pharmaceutical drug
|
| gptkbp:analyzes |
statistical methods
clinical researchers IND_application_submitted |
| gptkbp:chemicalFormula |
small molecule
|
| gptkbp:clinicalTrials |
Phase 1
Phase 2 to be determined multiple sites obtained secured funding double-blind study not yet published Sigmoid Pharma ongoing oversight |
| gptkbp:collaborations |
biopharmaceutical companies
academic-industry partnership |
| gptkbp:collection |
patient-reported outcomes
|
| gptkbp:community_service |
efficacy and safety
to be identified |
| gptkbp:communityPartnerships |
with healthcare organizations
|
| gptkbp:contraindication |
monitored
|
| gptkbp:customerFeedback |
collected during trials
|
| gptkbp:dataUsage |
collaborative efforts
|
| gptkbp:developedBy |
Sigmoid Pharma
|
| gptkbp:dosageForm |
tablet
|
| gptkbp:firstClaim |
treatment of ulcerative colitis
treatment of Crohn's disease |
| gptkbp:formulation |
tablet formulation
|
| gptkbp:funding |
private investment
|
| gptkbp:future_plans |
clinical trials
|
| gptkbp:hasPopulation |
diverse demographics
|
| gptkbp:healthcare |
ongoing
|
| https://www.w3.org/2000/01/rdf-schema#label |
SIG716
|
| gptkbp:mandates |
autoimmune diseases
|
| gptkbp:marketSegment |
not yet marketed
|
| gptkbp:patentStatus |
patented
|
| gptkbp:productionCompany |
early development
|
| gptkbp:regulatoryCompliance |
pending
|
| gptkbp:research |
government grants
clinical research multi-year study |
| gptkbp:research_areas |
immunology
|
| gptkbp:researchAndDevelopment |
ongoing
|
| gptkbp:researchAreas |
improve treatment options
analyzed for trends |
| gptkbp:researchFocus |
gastroenterology
|
| gptkbp:researchInterest |
peer-reviewed journals
international partners various universities randomized controlled trials regulatory hurdles approved by ethics committee enhance patient quality of life to be published. potential to change treatment landscape new_therapeutic_approach |
| gptkbp:route |
oral
|
| gptkbp:safetyFeatures |
under evaluation
|
| gptkbp:sideEffect |
to be determined
|
| gptkbp:status |
investigational
|
| gptkbp:targets |
adults
inflammatory bowel disease immune modulation |
| gptkbp:triggerType |
modulates_immune_response
|